ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare.

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

Warren Buffett doesn't appear to be bullish about the market. But, he hasn't predicted a stock market crash this year for one ...

The ASX 200 flattened out to close a Thursday that saw Chemist Warehouse land on the bourse via Sigma. Mining stocks led the ...

The S&P 500 dropped 0.3% on Wednesday, Feb. 12, as hotter-than-expected inflation data in the January CPI report weighed on ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

Shares of CVS Health (NYSE: CVS) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results ...

U.S. equities dropped at midday when the January report on consumer prices showed inflation rose more than had been expected.

Wall Street stocks opened lower Wednesday following a report showing higher US inflation in January, dampening expectations for interest ...